Unspecified adrenocortical insufficiency
ICD-10 E27.40 is a billable code used to indicate a diagnosis of unspecified adrenocortical insufficiency.
Unspecified adrenocortical insufficiency refers to a condition where the adrenal glands do not produce adequate amounts of steroid hormones, particularly cortisol, which is crucial for various bodily functions including metabolism, immune response, and stress management. This condition can arise from various etiologies, including primary adrenal gland disorders, secondary insufficiency due to pituitary dysfunction, or tertiary insufficiency related to hypothalamic issues. Symptoms may include fatigue, weight loss, low blood pressure, and electrolyte imbalances. Diagnosis typically involves hormonal assays to measure cortisol levels, ACTH stimulation tests, and imaging studies to assess adrenal gland structure. Treatment often involves hormone replacement therapy, but the specific approach may vary depending on the underlying cause of the insufficiency. Accurate coding is essential for proper management and reimbursement, as it reflects the complexity of the patient's condition and the necessity for ongoing monitoring and treatment.
Detailed hormonal assay results, patient history, and treatment plans.
Patients presenting with fatigue, weight loss, and hypotension; patients with known adrenal disorders requiring monitoring.
Endocrinologists must ensure that all relevant lab results and clinical findings are documented to support the diagnosis.
Comprehensive patient history, physical examination findings, and lab results.
Patients with unexplained fatigue or weight loss; patients with chronic illnesses that may affect adrenal function.
Internal medicine practitioners should be aware of the potential for adrenal insufficiency in patients with chronic illnesses.
Used to confirm diagnosis of adrenal insufficiency.
Document the reason for the test and the results.
Endocrinologists should ensure that the test is interpreted in the context of clinical findings.
Common symptoms include fatigue, weight loss, low blood pressure, dizziness, and electrolyte imbalances. Patients may also experience increased pigmentation of the skin and cravings for salt.
Diagnosis typically involves measuring serum cortisol levels, conducting an ACTH stimulation test, and possibly imaging studies to assess adrenal gland structure.
Treatment usually involves hormone replacement therapy, specifically glucocorticoids, to manage symptoms and restore normal hormone levels.
